Suppression of macrophage nitric oxide production by melanoma: mediation by a melanoma-derived product.
The tumour-bearing state is known to induce immune dysfunction that contributes to increased infectious complications and tumour progression. However, the mechanisms underlying this immunosuppression remain unclear. This study investigated in a murine model the effects of melanoma growth on nitric oxide (NO) production by peritoneal macrophages in vivo and in vitro. B16 and K1735 melanoma cells were inoculated subcutaneously into C57BL/6 and C3H/HeN mice, respectively. Stimulated NO production by elicited peritoneal macrophages was examined in control and melanoma- bearing mice. An in vitro system was established to assess the effects of co-culturing melanoma cells (B16 and K1735) or melanoma-conditioned medium with normal peritoneal macrophages on subsequent NO production. NO production was significantly suppressed in macrophages from melanoma-bearing mice. Co-culture of normal macrophages with melanoma cells in a transwell system or with melanoma-conditioned media in vitro reproduced the defects observed in vivo without affecting macrophage viability, pointing to a melanoma-derived product as the basis for the observed suppression of NO production. This inhibition required RNA and protein synthesis and was dose and time dependent. Using inhibition profiles and neutralizing antibodies, it was demonstrated that this melanoma inhibitory activity was distinct from known NO inhibitors. Preliminary characterization attributed this activity to a melanoma-secreted protein moiety.
Naama
H A
HA
Department of Surgery, Weill Medical College of Cornell University, 525 E 68 St, F739, NY 10021, USA.
McCarter
M D
MD
Mack
V E
VE
Evoy
D A
DA
Hill
A D
AD
Shou
J
J
Daly
J M
JM
D000818:Animals; D018920:Coculture Techniques; D017077:Culture Media, Conditioned / Q000378:metabolism; D003513:Cycloheximide / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005260:Female; D008264:Macrophages / Q000378:metabolism; D017737:Macrophages, Peritoneal / Q000378:metabolism*; D008545:Melanoma / Q000378:metabolism*; D008546:Melanoma, Experimental; D051379:Mice; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D009368:Neoplasm Transplantation; D009569:Nitric Oxide / Q000096:biosynthesis*; D010537:Peritoneum / Q000378:metabolism; D012313:RNA / Q000378:metabolism; D013997:Time Factors; D014407:Tumor Cells, Cultured
D017077:Culture Media, Conditioned; D003609:Dactinomycin; D009569:Nitric Oxide; D012313:RNA; D003513:Cycloheximide